Mats G. Hansson

Mats G. Hansson

Mats G. Hansson

Senior Professor of Biomedical Ethics
 

Mats Hansson is Senior Professor and the former director of the Centre for Research Ethics & Bioethics and has conducted extensive research in biomedical ethics as principal investigator in several multi-disciplinary research projects dealing with issues ranging from ethical, social and legal aspects of the implementation of genetic diagnosis in clinical practice and the use of human tissue materials in research, to clinical and medical ethics. He holds an undergraduate degree in biology (1974) and a doctoral degree of theology (1991). Mats Hansson is Professor of Biomedical Ethics. 

E-mail: Mats.Hansson@crb.uu.se
Phone: +46 18 471 61 97

Research

Mats G. Hansson leads work packages on ethical, legal and social issues in several EU projects on biobank and registry research. He is the principal investigator in Mind the Risk and one of the co-ordinators of BBMRI-ERIC's ELSI common service.

PhD Supervision

Current

Completed

Recently in the media

Recent publications

  • Matar, Amal; Hansson, Mats G.; Höglund, Anna T.

    "A perfect society": Swedish policymakers' ethical and social views on preconception expanded carrier screening

    Part of Journal of Community Genetics, p. 267-280, 2019.

    Open access
  • Grauman, Åsa; Hansson, Mats G.; James, Stefan K; Veldwijk, Jorien et al.

    Exploring research participants' perceptions of cardiovascular risk information-Room for improvement and empowerment

    Part of Patient Education and Counseling, p. 1528-1534, 2019.

    Open access
  • Hansson, Mats G.; Holm, Anna; Segerdahl, Pär

    MIND THE RISK · DEN GENETISKA RISKINFORMATIONENS ETIK FÖR INDIVID OCH SAMHÄLLE: SLUTRAPPORT FRÅN ETT FORSKNINGSPROGRAM

    Makadam Förlag, 2019.

    Open access
  • Schölin Bywall, Karin; Veldwijk, Jorien; Hansson, Mats G.; Kihlbom, Ulrik

    Patient Perspectives on the Value of Patient Preference Information in Regulatory Decision Making: A Qualitative Study in Swedish Patients with Rheumatoid Arthritis

    Part of Patient, p. 297-305, 2019.

    Open access
  • Frygner-Holm, Sara; Russ, Sandra; Quitmann, Julia; Ring, Lena et al.

    Pretend Play as an Intervention for Children With Cancer: A Feasibility Study

    Part of Journal of Pediatric Oncology Nursing, p. 65-75, 2019.

  • Viberg, Jennifer; Langenskiöld, Sophie; Segerdahl, Pär; Hansson, Mats G. et al.

    Research participants' preferences for receiving genetic risk information: a discrete choice experiment

    Part of Genetics in Medicine, p. 2381-2389, 2019.

  • Grauman, Åsa; Hansson, Mats G.; Puranen, Arvid; James, Stefan et al.

    Short-term mental distress in research participants after receiving cardiovascular risk information

    Part of PLoS ONE, 2019.

    Open access
  • Matar, Amal; Hansson, Mats G.; Höglund, Anna T

    Values and value conflicts in implementation and use of preconception expanded carrier screening: an expert interview study

    Part of BMC Medical Ethics, 2019.

    Open access
  • Renzi, Chiara; Provencal, Nadine; Bassil, Katherine C; Evers, Kathinka et al.

    From Epigenetic Associations to Biological and Psychosocial Explanations in Mental Health.

    Part of Progress in Molecular Biology and Translational Science, p. 299-323, 2018.

  • Hansson, Mats G.; Bouder, Frederic; Howard, Heidi Carmen

    Genetics and risk - an exploration of conceptual approaches to genetic risk

    Part of Journal of Risk Research, p. 101-108, 2018.

Biobank and registry ethics & law

For many years, researchers at CRB have provided constructive advise on how to deal with ethical and legal aspects of research using human tissue material and personal data. We have collaborated with biomedical scientists and published our findings in peer reviewed journals. As a summary of this research we have compiled a list of publications with abstracts. We have grouped them thematically to help you find the ones you might be interested in reading. Our publications deal with ethical frameworks and policy, regulatory aspects of biobank and registry research, informed consent, ethical review, integrity concerns, trust, genetic testing, indicental findings, commercialization, public and patient perceptions, rare diseases, children & biobanks & genetics, and biobank studies.

Download our biobank and registry report

Biobank and registry ethics & law, report cover

Biobanks as resources for health

Hansson & Levin (eds) 2003

The potential benefits of biomedicine and biotechnology are considerable, but this is also an area of science and medicine that is sometimes found controversial. Decisions made by scientists, by health care professionals and by policymakers must be well informed and based on knowledge and sound research. Legal experts concerned with public law and intellectual property rights, philosophers and social pharmacists have been collaborating with geneticists, pathologists and doctors in several research projects in order to seek the kind of biobank management that would satisfy the interests of both the research community and the general public as regards new medicines and forms of treatment, whilst protecting the integrity of the individual. A summary of that research is presented in this book.

Download Biobanks as resources for health

Biobanks as resources for health, Hansson & Levin, cover